Bruce W. Bode
Elite in Type 2 Diabetes (T2D)

Dr. Bruce W. Bode

Internal Medicine | Endocrinology
Piedmont Healthcare
Atlanta Diabetes Associates
1800 Howell Mill Road, Suite 450, 
Atlanta, GA 
Accepting New Patients
Offers Telehealth

Elite in Type 2 Diabetes (T2D)
Piedmont Healthcare
Atlanta Diabetes Associates
1800 Howell Mill Road, Suite 450, 
Atlanta, GA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Bruce Bode is an Internal Medicine specialist and an Endocrinologist in Atlanta, Georgia. Dr. Bode is rated as an Elite provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Type 1 Diabetes (T1D), Low Blood Sugar, Type 2 Diabetes (T2D), and Maturity Onset Diabetes of the Young. Dr. Bode is currently accepting new patients.

His clinical research consists of co-authoring 178 peer reviewed articles and participating in 32 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 62 articles and participated in 13 clinical trials in the study of Type 2 Diabetes (T2D).

Graduate Institution
Emory University School Of Medicine, 1981
Residency
Emory University Hospital, Internal Medicine, 1984
Specialties
Internal Medicine
Endocrinology
Licenses
Internal Medicine in GA
Board Certifications
American Board Of Internal Medicine
Fellowships
American College of Surgeons, Endocrinology, 1996
Hospital Affiliations
Piedmont Hospital, Inc
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alliant Health
  • HMO
  • PPO
Ambetter
  • EPO
  • HMO
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Clover Health
  • INSURANCE PLAN
  • MEDICARE MAPD
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Friday Health

Accepted plan types not found. Please verify directly with the provider.

Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Nippon Life
  • INSURANCE PLAN
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Sentara Healthcare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE ASSISTANCE PROGRAM
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
Sutter Health
  • HMO
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 31 Less Insurance Carriers -

Locations

Atlanta Diabetes Associates
1800 Howell Mill Road, Suite 450, Atlanta, GA 30318
Call: 404-355-4393

Additional Areas of Focus

Dr. Bode has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Hypoparathyroidism
Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


30 Clinical Trials

The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
Enrollment Status: Completed
Publish Date: August 24, 2025
Intervention Type: Drug
Study Drugs: Tirzepatide, Dulaglutide
Study Phase: Phase 3
Multi-center, Randomized, Parallel, Adaptive, Controlled Trial in Adult and Pediatric Patients With Type 1 Diabetes Using Hybrid Closed Loop System and Control (CSII, MDI and SAP) at Home
Multi-center, Randomized, Parallel, Adaptive, Controlled Trial in Adult and Pediatric Patients With Type 1 Diabetes Using Hybrid Closed Loop System and Control (CSII, MDI and SAP) at Home
Enrollment Status: Completed
Publish Date: August 19, 2025
Intervention Type: Device
Study Phase: Not Applicable
A Post Approval Study to Evaluate the Safety and Effectiveness of the Eversense® Continuous Glucose Monitoring (CGM) System Used Non-adjunctively
A Post Approval Study to Evaluate the Safety and Effectiveness of the Eversense® Continuous Glucose Monitoring (CGM) System Used Non-adjunctively
Enrollment Status: Active_not_recruiting
Publish Date: August 13, 2025
Intervention Type: Device
Study Phase: Not Applicable
Evaluation of the MiniMed™ 780G System in Type 1 Adult and Pediatric Subjects Utilizing Insulin Fiasp® (Insulin Aspart Injection)
Evaluation of the MiniMed™ 780G System in Type 1 Adult and Pediatric Subjects Utilizing Insulin Fiasp® (Insulin Aspart Injection)
Enrollment Status: Completed
Publish Date: June 22, 2025
Intervention Type: Device
Study Phase: Not Applicable
A Post- Approval Study to Evaluate the Long-term Safety and Effectiveness of the Eversense® Continuous Glucose Monitoring (CGM) System
A Post- Approval Study to Evaluate the Long-term Safety and Effectiveness of the Eversense® Continuous Glucose Monitoring (CGM) System
Enrollment Status: Completed
Publish Date: June 12, 2025
Intervention Type: Device
Study Phase: Not Applicable
Evaluating the Safety and Effectiveness of the Omnipod® 5 Automated Insulin Delivery System in Patients With Type 2 Diabetes
Evaluating the Safety and Effectiveness of the Omnipod® 5 Automated Insulin Delivery System in Patients With Type 2 Diabetes
Enrollment Status: Completed
Publish Date: April 18, 2025
Intervention Type: Device
Study Phase: Not Applicable
In-Home Study With MiniMed™ 780G Pump Automated Control in Type 2 - Evaluation of the AHCL System in Adults With Insulin-requiring Type 2 Diabetes
In-Home Study With MiniMed™ 780G Pump Automated Control in Type 2 - Evaluation of the AHCL System in Adults With Insulin-requiring Type 2 Diabetes
Enrollment Status: Completed
Publish Date: February 21, 2025
Intervention Type: Device
Study Phase: Not Applicable
Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adult and Pediatric Subjects Utilizing Lyumjev® Insulin Lispro-aabc
Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adult and Pediatric Subjects Utilizing Lyumjev® Insulin Lispro-aabc
Enrollment Status: Completed
Publish Date: January 15, 2025
Intervention Type: Device
Study Phase: Not Applicable
Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adult and Pediatric Subjects
Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adult and Pediatric Subjects
Enrollment Status: Completed
Publish Date: January 14, 2025
Intervention Type: Device
Study Phase: Not Applicable
Use of the Guardian™ Connect System With Smart Connected Devices
Use of the Guardian™ Connect System With Smart Connected Devices
Enrollment Status: Completed
Publish Date: December 10, 2024
Intervention Type: Device
Study Phase: Not Applicable
PROMISE Study: A Prospective, Multicenter Evaluation of Accuracy and Safety of an Implantable Continuous Glucose Sensor Lasting up to 180 Days
PROMISE Study: A Prospective, Multicenter Evaluation of Accuracy and Safety of an Implantable Continuous Glucose Sensor Lasting up to 180 Days
Enrollment Status: Completed
Publish Date: August 20, 2024
Intervention Type: Device
Study Phase: Not Applicable
Efficacy and Safety of Tirzepatide Once Weekly in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-2)
Efficacy and Safety of Tirzepatide Once Weekly in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-2)
Enrollment Status: Completed
Publish Date: April 08, 2024
Intervention Type: Other, Drug
Study Drug: Tirzepatide
Study Phase: Phase 3
Evaluating the Safety and Effectiveness of the Omnipod Horizon™ Automated Glucose Control System in Children With Type 1 Diabetes Aged 2.0-5.9 Years: Preschool Cohort
Evaluating the Safety and Effectiveness of the Omnipod Horizon™ Automated Glucose Control System in Children With Type 1 Diabetes Aged 2.0-5.9 Years: Preschool Cohort
Enrollment Status: Completed
Publish Date: February 14, 2024
Intervention Type: Device
Study Phase: Not Applicable
Evaluation of Updated Continuous Glucose Monitoring (CGM) Form Factor in Adults, Adolescents and Pediatrics
Evaluation of Updated Continuous Glucose Monitoring (CGM) Form Factor in Adults, Adolescents and Pediatrics
Enrollment Status: Completed
Publish Date: June 02, 2023
Intervention Type: Device
Study Phase: Not Applicable
Feasibility Study With Personalized Closed Loop (PCL)
Feasibility Study With Personalized Closed Loop (PCL)
Enrollment Status: Completed
Publish Date: May 09, 2023
Intervention Type: Device
Study Phase: Not Applicable
A Study of LY900014 in Participants With Type 2 Diabetes Using Continuous Glucose Monitoring
A Study of LY900014 in Participants With Type 2 Diabetes Using Continuous Glucose Monitoring
Enrollment Status: Completed
Publish Date: March 03, 2023
Intervention Type: Drug
Study Drugs: LY900014, Insulin Glargine
Study Phase: Phase 3
A Phase 2, Randomized, Parallel, Open-Label Comparator-Controlled Trial to Evaluate the Safety and Efficacy of LY3209590 in Study Participants With Type 1 Diabetes Mellitus Previously Treated With Multiple Daily Injection Therapy
A Phase 2, Randomized, Parallel, Open-Label Comparator-Controlled Trial to Evaluate the Safety and Efficacy of LY3209590 in Study Participants With Type 1 Diabetes Mellitus Previously Treated With Multiple Daily Injection Therapy
Enrollment Status: Completed
Publish Date: October 27, 2022
Intervention Type: Drug
Study Drugs: LY3209590, Insulin Degludec
Study Phase: Phase 2
An Exploratory Study Assessing Time in Target Glucose Range Using a New Titration Scheme of LY900014 and Insulin Degludec in Patients With Type 1 Diabetes
An Exploratory Study Assessing Time in Target Glucose Range Using a New Titration Scheme of LY900014 and Insulin Degludec in Patients With Type 1 Diabetes
Enrollment Status: Completed
Publish Date: June 03, 2022
Intervention Type: Drug
Study Drugs: LY900014, Insulin Degludec
Study Phase: Phase 2
Evaluation of Extended Wear Infusion Set (EWIS) in Patients With Type 1 Diabetes
Evaluation of Extended Wear Infusion Set (EWIS) in Patients With Type 1 Diabetes
Enrollment Status: Completed
Publish Date: October 01, 2021
Intervention Type: Device
Study Phase: Not Applicable
Post Approval Study for Non-Adjunctive Use of Dexcom G5 and G6 CGM System for Diabetes Management
Post Approval Study for Non-Adjunctive Use of Dexcom G5 and G6 CGM System for Diabetes Management
Enrollment Status: Unknown
Publish Date: September 21, 2021
Intervention Type: Device
Continuous Glucose Monitoring (CGM) in Type 2 Diabetes (T2D) Basal Insulin Users: The Mobile Study (MOBILE)
Continuous Glucose Monitoring (CGM) in Type 2 Diabetes (T2D) Basal Insulin Users: The Mobile Study (MOBILE)
Enrollment Status: Completed
Publish Date: April 21, 2021
Intervention Type: Device
Study Phase: Not Applicable
Continuous Glucose Monitoring & Management In Type 2 Diabetes
Continuous Glucose Monitoring & Management In Type 2 Diabetes
Enrollment Status: Completed
Publish Date: March 22, 2021
Intervention Type: Device
Study Phase: Not Applicable
Fixed Rate Continuous Subcutaneous Glucagon Infusion (CSGI) vs Placebo in Type 1 Diabetes Mellitus Patients With Recurrent Severe Hypoglycemia: Effects on Counter-Regulatory Responses to Insulin-Induced Hypoglycemia
Fixed Rate Continuous Subcutaneous Glucagon Infusion (CSGI) vs Placebo in Type 1 Diabetes Mellitus Patients With Recurrent Severe Hypoglycemia: Effects on Counter-Regulatory Responses to Insulin-Induced Hypoglycemia
Enrollment Status: Terminated
Publish Date: February 21, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Humalog in Adults With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Humalog in Adults With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion
Enrollment Status: Completed
Publish Date: January 22, 2021
Intervention Type: Drug
Study Phase: Phase 3
Evaluation of LY900014 in a Medtronic Pump
Evaluation of LY900014 in a Medtronic Pump
Enrollment Status: Completed
Publish Date: October 29, 2020
Intervention Type: Drug
Study Phase: Phase 2
A Performance Evaluation of the Harmony 1 Sensors in Adults and Pediatrics
A Performance Evaluation of the Harmony 1 Sensors in Adults and Pediatrics
Enrollment Status: Withdrawn
Publish Date: September 29, 2020
Intervention Type: Device
Study Phase: Not Applicable
G-Pen (Glucagon Injection) Compared to GlucaGen® Hypokit® (Glucagon) for Induced Hypoglycemia Rescue in Adults With T1D: A Phase 3 Multi-center, Randomized, Controlled, Single Blind, 2-way Crossover Study to Evaluate Efficacy and Safety
G-Pen (Glucagon Injection) Compared to GlucaGen® Hypokit® (Glucagon) for Induced Hypoglycemia Rescue in Adults With T1D: A Phase 3 Multi-center, Randomized, Controlled, Single Blind, 2-way Crossover Study to Evaluate Efficacy and Safety
Enrollment Status: Completed
Publish Date: May 22, 2020
Intervention Type: Drug
Study Phase: Phase 3
G-Pen™ (Glucagon Injection) Compared to Lilly Glucagon (Glucagon for Injection [RDNA Origin]) for Induced Hypoglycemia Rescue in Adults With T1D: a Phase 3 B Multi-Centered, Randomized, Controlled, Single Blind, 2-Way Crossover Study to Evaluate Efficacy and Safety
G-Pen™ (Glucagon Injection) Compared to Lilly Glucagon (Glucagon for Injection [RDNA Origin]) for Induced Hypoglycemia Rescue in Adults With T1D: a Phase 3 B Multi-Centered, Randomized, Controlled, Single Blind, 2-Way Crossover Study to Evaluate Efficacy and Safety
Enrollment Status: Completed
Publish Date: February 17, 2020
Intervention Type: Drug
Study Phase: Phase 3
A Prospective, Randomized, Double-Blind, Crossover Comparison Evaluating Compatibility and Safety of LY900014 and Insulin Lispro With an External Continuous Subcutaneous Insulin Infusion System in Adult Patients With Type 1 Diabetes (PRONTO-Pump)
A Prospective, Randomized, Double-Blind, Crossover Comparison Evaluating Compatibility and Safety of LY900014 and Insulin Lispro With an External Continuous Subcutaneous Insulin Infusion System in Adult Patients With Type 1 Diabetes (PRONTO-Pump)
Enrollment Status: Completed
Publish Date: October 08, 2019
Intervention Type: Drug
Study Phase: Phase 3
Wireless Innovation for Seniors With Diabetes Mellitus (WISDM)
Wireless Innovation for Seniors With Diabetes Mellitus (WISDM)
Enrollment Status: Completed
Publish Date: September 12, 2019
Intervention Type: Device
Study Phase: Not Applicable
View 29 Less Clinical Trials

177 Total Publications

Erratum. Use of the Omnipod 5 Automated Insulin Delivery System Activity Feature Reduces Insulin Delivery and Attenuates the Drop in Glycemia Associated With Exercise in a Randomized Controlled Trial Diabetes Care 2025;48:1598-1606.
Erratum. Use of the Omnipod 5 Automated Insulin Delivery System Activity Feature Reduces Insulin Delivery and Attenuates the Drop in Glycemia Associated With Exercise in a Randomized Controlled Trial Diabetes Care 2025;48:1598-1606.
Journal: Diabetes care
Published: October 20, 2025
View All 177 Publications
Similar Doctors
Elite in Type 2 Diabetes (T2D)
Dr. Guillermo E. Umpierrez
Endocrinology
Elite in Type 2 Diabetes (T2D)
Dr. Guillermo E. Umpierrez
Endocrinology

Emory Medical Care Foundation Inc

80 Jesse Hill Jr Dr Se, 
Atlanta, GA 
 (4.1 miles away)
404-616-1000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Guillermo Umpierrez is an Endocrinologist in Atlanta, Georgia. Dr. Umpierrez is rated as an Elite provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Diabetic Ketoacidosis, Low Blood Sugar, Type 2 Diabetes (T2D), and Diabetic Hyperglycemic Hyperosmolar Syndrome.

Elite in Type 2 Diabetes (T2D)
Dr. Francisco Pasquel
Endocrinology
Elite in Type 2 Diabetes (T2D)
Dr. Francisco Pasquel
Endocrinology

Emory Medical Care Foundation Inc

80 Jesse Hill Jr Dr Se, 
Atlanta, GA 
 (4.1 miles away)
404-616-1000
Experience:
21+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Francisco Pasquel is an Endocrinologist in Atlanta, Georgia. Dr. Pasquel has been practicing medicine for over 21 years and is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Diabetic Ketoacidosis, Type 2 Diabetes (T2D), Low Blood Sugar, Diabetic Hyperglycemic Hyperosmolar Syndrome, and Coronary Artery Bypass Graft (CABG).

Elite in Type 2 Diabetes (T2D)
Dr. Maya Fayfman
Endocrinology
Elite in Type 2 Diabetes (T2D)
Dr. Maya Fayfman
Endocrinology

Emory Medical Care Foundation Inc

80 Jesse Hill Jr Dr Se, 
Atlanta, GA 
 (4.1 miles away)
404-616-1000
Experience:
16+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Maya Fayfman is an Endocrinologist in Atlanta, Georgia. Dr. Fayfman has been practicing medicine for over 16 years and is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Type 2 Diabetes (T2D), Diabetic Ketoacidosis, Low Blood Sugar, and Diabetic Hyperglycemic Hyperosmolar Syndrome.

VIEW MORE TYPE 2 DIABETES (T2D) DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Bode's expertise for a condition
ConditionClose
  • Elite
  • Low Blood Sugar
    Dr. Bode is
    Elite
    . Learn about Low Blood Sugar.
    See more Low Blood Sugar experts
  • Maturity Onset Diabetes of the Young
    Dr. Bode is
    Elite
    . Learn about Maturity Onset Diabetes of the Young.
    See more Maturity Onset Diabetes of the Young experts
  • Type 1 Diabetes (T1D)
    Dr. Bode is
    Elite
    . Learn about Type 1 Diabetes (T1D).
    See more Type 1 Diabetes (T1D) experts
  • Type 2 Diabetes (T2D)
    Dr. Bode is
    Elite
    . Learn about Type 2 Diabetes (T2D).
    See more Type 2 Diabetes (T2D) experts
  • Distinguished
  • Diabetic Ketoacidosis
    Dr. Bode is
    Distinguished
    . Learn about Diabetic Ketoacidosis.
    See more Diabetic Ketoacidosis experts
  • Hypothyroidism
    Dr. Bode is
    Distinguished
    . Learn about Hypothyroidism.
    See more Hypothyroidism experts
  • Obesity
    Dr. Bode is
    Distinguished
    . Learn about Obesity.
    See more Obesity experts
  • Obesity in Children
    Dr. Bode is
    Distinguished
    . Learn about Obesity in Children.
    See more Obesity in Children experts
  • Vitamin D Deficiency
    Dr. Bode is
    Distinguished
    . Learn about Vitamin D Deficiency.
    See more Vitamin D Deficiency experts
  • Advanced
  • Abdominal Obesity Metabolic Syndrome
    Dr. Bode is
    Advanced
    . Learn about Abdominal Obesity Metabolic Syndrome.
    See more Abdominal Obesity Metabolic Syndrome experts
  • Addison's Disease
    Dr. Bode is
    Advanced
    . Learn about Addison's Disease.
    See more Addison's Disease experts
  • Cushing's syndrome
    Dr. Bode is
    Advanced
    . Learn about Cushing's syndrome.
    See more Cushing's syndrome experts
  • Cushing's syndrome due to Adrenal Tumor
    Dr. Bode is
    Advanced
    . Learn about Cushing's syndrome due to Adrenal Tumor.
    See more Cushing's syndrome due to Adrenal Tumor experts
  • Cytochrome C Oxidase Deficiency
    Dr. Bode is
    Advanced
    . Learn about Cytochrome C Oxidase Deficiency.
    See more Cytochrome C Oxidase Deficiency experts
  • Diabetes Insipidus (DI)
    Dr. Bode is
    Advanced
    . Learn about Diabetes Insipidus (DI).
    See more Diabetes Insipidus (DI) experts
View All 34 Advanced Conditions
  • Experienced
  • Acute Adrenal Crisis
    Dr. Bode is
    Experienced
    . Learn about Acute Adrenal Crisis.
    See more Acute Adrenal Crisis experts
  • Adrenal Gland Adenoma
    Dr. Bode is
    Experienced
    . Learn about Adrenal Gland Adenoma.
    See more Adrenal Gland Adenoma experts
  • Alopecia Areata
    Dr. Bode is
    Experienced
    . Learn about Alopecia Areata.
    See more Alopecia Areata experts
  • Anaplastic Thyroid Cancer
    Dr. Bode is
    Experienced
    . Learn about Anaplastic Thyroid Cancer.
    See more Anaplastic Thyroid Cancer experts
  • Autosomal Dominant Hypocalcemia
    Dr. Bode is
    Experienced
    . Learn about Autosomal Dominant Hypocalcemia.
    See more Autosomal Dominant Hypocalcemia experts
  • Autosomal Recessive Hypotrichosis
    Dr. Bode is
    Experienced
    . Learn about Autosomal Recessive Hypotrichosis.
    See more Autosomal Recessive Hypotrichosis experts
View All 75 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Close
      0 / 1000

      Please provide us with the below insurance information:

              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.